drugset / Trial / NCT01655303

Rate Control in Atrial Fibrillation

NCT01655303

Phase 4 Completed 90 enrolled Tehran University of Medical Sciences
RandomizedParallel-groupDouble-blindTreatment

Summary

Rate control in atrial fibrillation is a usual battle in emergency departments. Oral medications have a natural superiority to intravenous ones because they are easy-to-use and decrease the workload in busy emergency departments. This study wants to find an effective oral medication for rate control in rapid ventricular response atrial fibrillation. Propranolol and Metoprolol, Diltiazem and Verapamil are compared in patients with a stable hemodynamic status.

Timeline

Start
2011-02
Primary completion
2011-12
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Diltiazem Small molecule 60 mg Oral
Subject Metoprolol Other / unclassified 50 mg
Subject Propranolol Small molecule 40 mg Oral
Subject Verapamil Other / unclassified 40 mg Oral

Indications